A Study of FDA018-ADC in Patients With Advanced Solid Tumors
Clinical trial NCT05174637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05174637
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2029-12-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.